Search

everythinglearnresearchcommunity

for

Search:↓

In 2017, Spanish dermatologists commonly prescribed topical minoxidil, oral finasteride, and nutricosmetics for hair loss, with oral contraceptives also used for premenopausal women. Less common were oral dutasteride, due to side effects, and newer, more expensive treatments like topical finasteride and Low-Level Laser Therapy. The conclusion is that there's a need for prescription guidelines due to varied treatment approaches.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

The new delivery method for dutasteride is more effective and has fewer side effects.

Topical dutasteride shows promise for hair loss but needs more research.

Dutasteride is more effective than finasteride for hair loss treatment.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

Dutasteride injections can help hair growth in androgenic alopecia but need more research for long-term use.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

New and existing treatments for hair loss show promise, with some being more effective for men and others for women.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Dutasteride may help stabilize Frontal Fibrosing Alopecia, but more research is needed.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

The new treatment regimen was effective in promoting significant hair growth in all 15 male patients with androgenic alopecia.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

Finasteride and dutasteride can cause severe, lasting side effects.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Hair transplantation is the best treatment for hair loss, with new technologies improving results, and stem cell and gene therapies may treat severe baldness in the future.

The conclusion is that individualized treatment and proper medication use are crucial in men's health, with specific recommendations for ED, BPH, and prostate cancer management.

The review provided information on various treatments to stop hair thinning and increase hair density in people with common genetic hair loss.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Long-term use of certain prostate drugs can worsen erectile dysfunction by changing penile tissue, especially in rats with high blood pressure.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

The document concludes that treatments for hair loss in transgender and gender-diverse individuals include topical solutions, oral medications, laser therapy, and hair restoration procedures, with progress assessed after 6-12 months.